Adam S. Grossman stock trades
President and CEO of ADMA Biologics
5 open-market trades reported in the last 12 months: 5 sales for $1.7M. Every sale was under a trading plan set up in advance. The newest was filed Mar 17.
Where Adam S. Grossman files
Each title as their newest Form 4 there gives it, and the open-market trades there in the last 12 months. Open any stock for its score. Pro members see every stock ranked.
| Company | Trades | Quality Score |
|---|---|---|
| 5 |
Adam S. Grossman's trades, as filed
Open-market buys and sales, newest first, each with its Form 4 on the SEC's site. A Plan tag marks a sale under a trading plan set up in advance.
| Stock | Trade | Traded |
|---|---|---|
| SellPlan$318K | Mar 16SEC filing | |
| SellPlan$338K | Feb 17SEC filing | |
| SellPlan$416K | Dec 15, 2025SEC filing |
2 more trades on record, and 10 other filings (option exercises and tax withholdings). Pro members see every trade, the shares Adam S. Grossman held after each, and every filing.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.